Diagnostic Precision for Tc-99m Cardiac Amyloid Imaging: Master the Latest Techniques for Improved Patient Care
ASNC is introducing a unique opportunity for you to evaluate your Tc-99m cardiac amyloid imaging skills.
Through an interactive course you will:
- Assess your ability to read Tc-99m pyrophosphate (Tc-99m PYP) studies before and after the lecture by experts
- Improve your understanding of imaging and interpreting Tc-99m PYP/HMDP studies
- Increase diagnostic accuracy and reduce the number of false positive studies
- Compare your competence with that of other physician readers
This complimentary course is offered through ASNC’s Education All-Access platform, available OnDemand to best fit your schedule. Upon completion, each learner will receive a report from each assessment denoting success and improvement.
Overview
The overall goal of this course is to improve the diagnostic skills of physicians performing, interpreting, and reporting technetium-99m pyrophosphate (Tc-99m PYP) studies. Optimized image analysis and informative reporting can affect multiple levels of patient management. Accurate imaging interpretation leads to a timely diagnosis, early initiation of transthyretin amyloidosis (ATTR) therapy, more specific heart failure treatment and thus improves both short- and long-term patient outcomes. Furthermore, reading physician confidence will improve through better understanding of the nuances of Tc-99m PYP studies and will result in enhanced communication with referring clinicians.
The first part of the course will involve learner self-assessment by reading 25 planar and 25 SPECT Tc-99m PYP studies, with image interpretation data collected for analysis. Each case has one question to be answered. Following the initial case reading assessment, participants will listen to a discussion of best practices and comparisons of Tc-99m PYP image acquisition using planar, SPECT, SPECT/CT and CZT imaging systems, 1- versus 3-hour imaging, quantification of tracer uptake, and use of Tc-99m HMDP, led by three imaging experts. The final part of this initiative will involve a follow-up assessment with participants reading an additional 25 planar and 25 SPECT Tc-99m PYP images to measure post-intervention learning.
Pricing
Complimentary for all participants
Credits
5 CME credits
Objectives
Following completion of this activity, learners will be able to:
- Demonstrate improvement in the accuracy of their image interpretation in the diagnosis of ATTR-CM
- Improve their confidence of reading and reporting Tc-99m cardiac amyloid imaging studies in patients suspected to have ATTR-CM
- Compare performance results to those of their peers and experts
- Identify incongruency between planar and SPECT findings in diagnosing ATTR-CM
Target Audience
Nuclear Cardiologists, Cardiologists, Nuclear Medicine Physicians, Fellows-in-training
Course Chair
Associate Professor; Clinical Investigator; Director of Nuclear Cardiology;
Director of Stress Lab; Director of Cardiac Amyloid Clinic
University of Ottawa Heart Institute, Ottawa, ON
Faculty
Professor of Medicine, Professor of Imaging Sciences, Director of Nuclear Cardiology and Cardiac PET CT, University of Rochester Medical Center, Rochester, NY
Professor of Medicine, Richard S. Caligiuri Endowed Chair in Amyloidosis and Heart Failure, Associate Chief of Cardiology (Faculty Development), Director, Cardiac Amyloidosis Center, Director, Nuclear Cardiology and Cardiac Imaging Fellowship, University of Pittsburgh Medical Center, Pittsburgh, PA
Acknowledgment of Commercial Support
This activity is supported by an unrestricted educational grant from Pfizer Inc.
Event Format
OnDemand
Credit Type
CME
